UK markets close in 4 hours 54 minutes

National Health Investors, Inc. (WX6.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
47.20-0.20 (-0.42%)
As of 8:10AM CEST. Market open.
Currency in EUR

Valuation measures

Market cap (intra-day) 52.18B
Enterprise value 33.59B
Trailing P/E 16.25
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)6.87
Price/book (mrq)1.40
Enterprise value/revenue 311.32
Enterprise value/EBITDA 712.49

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 3-9.71%
S&P500 52-week change 332.94%
52-week high 365.00
52-week low 346.20
50-day moving average 350.33
200-day moving average 356.06

Share statistics

Avg vol (3-month) 383
Avg vol (10-day) 335
Shares outstanding 545.85M
Implied shares outstanding 6N/A
Float 844.01M
% held by insiders 14.74%
% held by institutions 167.55%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 43.06
Forward annual dividend yield 46.47%
Trailing annual dividend rate 34.21
Trailing annual dividend yield 38.88%
5-year average dividend yield 44.90
Payout ratio 4123.39%
Dividend date 3N/A
Ex-dividend date 429 Sept 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Jun 2021


Profit margin 48.63%
Operating margin (ttm)64.31%

Management effectiveness

Return on assets (ttm)4.08%
Return on equity (ttm)10.09%

Income statement

Revenue (ttm)317.2M
Revenue per share (ttm)7.02
Quarterly revenue growth (yoy)-11.90%
Gross profit (ttm)320.03M
EBITDA 287.31M
Net income avi to common (ttm)154.25M
Diluted EPS (ttm)2.90
Quarterly earnings growth (yoy)-11.70%

Balance sheet

Total cash (mrq)32.54M
Total cash per share (mrq)0.71
Total debt (mrq)1.44B
Total debt/equity (mrq)92.38
Current ratio (mrq)2.31
Book value per share (mrq)33.73

Cash flow statement

Operating cash flow (ttm)223.85M
Levered free cash flow (ttm)169.45M